Pfizer Completes Acquisition of Global Blood Therapeutics 

(marketscreener.com) Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient communityhttps://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/Pfizer-Completes-Acquisition-of-Global-Blood-Therapeutics-41933646/?utm_medium=RSS&utm_content=20221005